Revusiran API Manufacturers
compare suppliers & get competitive offers
No suppliers found
Sorry, there are currently no suppliers listed for this ingredient. Hopefully we can help you with other ingredients.
Notify me!
Want to be the first to find out when a supplier for Revusiran is listed?
Join our notification list by following this page.
Join our notification list by following this page.
List your company
Are you a supplier of Revusiran or other APIs and are you looking to list your company on Pharmaoffer?
Click the button below to find out more
Click the button below to find out more
Find CDMO
Looking for a CDMO/CMO that can help you with your pharmaceutical needs?
Click the button below to switch over to the contract services area of Pharmaoffer.
Click the button below to switch over to the contract services area of Pharmaoffer.
Looking for Revusiran API 1438322-82-7?
- Description:
- Here you will find a list of producers, manufacturers and distributors of Revusiran. You can filter on certificates such as GMP, FDA, CEP, Written Confirmation and more. Send inquiries for free and get in direct contact with the supplier of your choice.
- API | Excipient name:
- Revusiran
- Synonyms:
- Cas Number:
- 1438322-82-7
- DrugBank number:
- DB16309
- Unique Ingredient Identifier:
- ZE6EHM8Z3A
General Description:
Revusiran, identified by CAS number 1438322-82-7, is a notable compound with significant therapeutic applications. Revusiran is under investigation in clinical trial NCT02319005 (ENDEAVOUR: Phase 3 Multicenter Study of Revusiran (ALN-TTRSC) in Patients With Transthyretin (TTR) Mediated Familial Amyloidotic Cardiomyopathy (FAC)).
Categories:
Revusiran is categorized under the following therapeutic classes: Antisense Elements (Genetics), Molecular Probes, Nucleic Acid Probes, Nucleic Acids, Nucleic Acids, Nucleotides, and Nucleosides, RNA, Antisense, RNA, Small Untranslated, RNA, Untranslated. These classifications highlight the drug's diverse therapeutic applications and its importance in treating various conditions.